Use of artificial intelligence techniques for diagnosis of malignant pleural mesothelioma
暂无分享,去创建一个
[1] T. Yıldırım,et al. MEDICAL DIAGNOSIS ON PIMA INDIAN DIABETES USING GENERAL REGRESSION NEURAL NETWORKS , 2003 .
[2] Cengiz Sertkaya,et al. A Comparative Study on Chronic Obstructive Pulmonary and Pneumonia Diseases Diagnosis using Neural Networks and Artificial Immune System , 2009, Journal of Medical Systems.
[3] F. Ricceri,et al. Survival of pleural malignant mesothelioma in Italy: A population‐based study , 2009, International journal of cancer.
[4] C. A. van der Merwe,et al. Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] D. Dasgupta,et al. Advances in artificial immune systems , 2006, IEEE Computational Intelligence Magazine.
[6] Fevzullah Temurtas,et al. A comparative study on thyroid disease diagnosis using neural networks , 2009, Expert Syst. Appl..
[7] Krzysztof Trojanowski,et al. Searching for Memory in Artificial Immune System , 2002, Intelligent Information Systems.
[8] Mohammad Bagher Menhaj,et al. Training feedforward networks with the Marquardt algorithm , 1994, IEEE Trans. Neural Networks.
[9] S. Emri,et al. Prognostic significance of flow cytometric DNA analysis in patients with malignant pleural mesothelioma. , 2001, Lung cancer.
[10] Leandro Nunes de Castro,et al. The Clonal Selection Algorithm with Engineering Applications 1 , 2000 .
[11] Alberto Tesi,et al. On the Problem of Local Minima in Backpropagation , 1992, IEEE Trans. Pattern Anal. Mach. Intell..
[12] Geoffrey E. Hinton,et al. Learning internal representations by error propagation , 1986 .
[13] Fevzullah Temurtas,et al. Tuberculosis Disease Diagnosis Using Artificial Neural Networks , 2010, Journal of Medical Systems.
[14] S. Emri,et al. Assessment of environmental asbestos exposure in Turkey by bronchoalveolar lavage. , 1998, American journal of respiratory and critical care medicine.
[15] Orhan Engin,et al. ARTIFICIAL IMMUNE SYSTEMS AND APPLICATIONS IN INDUSTRIAL PROBLEMS , 2004 .
[16] H. Pass,et al. Malignant mesothelioma 2008 , 2008, Current opinion in pulmonary medicine.
[17] Fevzullah Temurtas,et al. An approach based on probabilistic neural network for diagnosis of Mesothelioma's disease , 2012, Comput. Electr. Eng..
[18] A. B. Watkins,et al. A resource limited artificial immune classifier , 2002, Proceedings of the 2002 Congress on Evolutionary Computation. CEC'02 (Cat. No.02TH8600).
[19] Dursun Delen,et al. Predicting breast cancer survivability: a comparison of three data mining methods , 2005, Artif. Intell. Medicine.
[20] I. Uçgun,et al. Prognostic factors in diffuse malignant pleural mesothelioma: effects of pretreatment clinical and laboratory characteristics. , 2001, Respiratory medicine.
[21] D. Sugarbaker,et al. Mesothelioma and radical multimodality therapy: who benefits? , 1995, Chest.
[22] Martin T. Hagan,et al. Neural network design , 1995 .
[23] Fevzullah Temurtas,et al. A study on quantitative classification of binary gas mixture using neural networks and adaptive neuro-fuzzy inference systems , 2006 .
[24] H. Bayram,et al. Malignant Pleural Mesothelioma Caused by Environmental Exposure to Asbestos in the Southeast of Turkey: CT Findings in 117 Patients , 2000, Respiration.
[25] K R Abrams,et al. Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems , 2000, Thorax.
[26] G. Dabouis,et al. Prognostic factors in diffuse malignant pleural mesothelioma. A study of 167 patients. , 1988, Chest.
[27] Tulay Yildirim,et al. Diagnosis of thyroid disease using artificial neural network methods , 2002, Proceedings of the 9th International Conference on Neural Information Processing, 2002. ICONIP '02..
[28] A. Hart,et al. Prognostic value of the serum tumour markers Cyfra 21-1 and tissue polypeptide antigen in malignant mesothelioma. , 1999, Lung cancer.
[29] F Levi,et al. The European mesothelioma epidemic , 1999, British Journal of Cancer.
[30] R. Damhuis,et al. Prognostic factors in malignant mesothelioma. , 2004, Lung cancer.
[31] D. Sugarbaker,et al. Multimodality management of malignant pleural mesothelioma. , 1998, Chest.
[32] A. Demir,et al. Environmental fibrous zeolite (erionite) exposure and malignant tumors other than mesothelioma. , 1996, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.
[33] Halife Kodaz,et al. Medical application of information gain based artificial immune recognition system (AIRS): Diagnosis of thyroid disease , 2009, Expert Syst. Appl..
[34] Abdurrahman Abakay,et al. Environmental malignant pleural mesothelioma in Southeast Turkey. , 2006, Saudi medical journal.
[35] S. Emri,et al. Malignant pleural mesothelioma due to environmental mineral fiber exposure in Turkey. Analysis of 135 cases. , 1992, Chest.
[36] N. Vogelzang. Malignant mesothelioma: diagnostic and management strategies for 1992. , 1992, Seminars in oncology.
[37] Richard P. Brent,et al. Fast training algorithms for multilayer neural nets , 1991, IEEE Trans. Neural Networks.
[38] A. Şenyiğit,et al. Incidence of Malignant Pleural Mesothelioma due to Environmental Asbestos Fiber Exposure in the Southeast of Turkey , 2000, Respiration.
[39] Fevzullah Temurtas,et al. A Study on Chronic Obstructive Pulmonary Disease Diagnosis Using Multilayer Neural Networks , 2008, Journal of Medical Systems.
[40] Nuray Can,et al. Warthin benzeri papiller tiroid karsinomu: Nadir bir tiroid tümörü , 2011 .
[41] Fevzullah Temurtas,et al. Chest diseases diagnosis using artificial neural networks , 2010, Expert Syst. Appl..